Specialist Care & Clinic Groups
Dental, veterinary, ophthalmic, and other consolidating specialties, from single sites to platform sales.
INDUSTRIES
Healthcare & Life Sciences
The sector is full of strong individual operators and very few of them at scale. We work with clinical groups and life-sciences businesses that have proven the model and stalled at the point where growth requires capital and structure the owner does not have. The value is real. The path to realising it is the missing part.
Fragmented operators in the same discipline are worth more together than apart, and founder-clinicians often reach a succession point with no structured way out. Both are the work we do.
We pursue roll-ups of fragmented clinical and services operators, and growth capital for groups past proof but short of scale.
We pursue roll-ups of fragmented clinical and services operators, and growth capital for groups past proof but short of scale.
01
01
Where we engage
•
Consolidation of fragmented clinical and services operators into a single platform
•
Growth capital for groups past proof of model but short of institutional scale
•
Succession and liquidity for founder-owners with no structured path out
•
Co-investment alongside the firm on platform builds in the sector
•
Cross-border structuring where operations span jurisdictions
02
02
Sector coverage
We advise founder and clinician owned businesses across care delivery, health services, and the technologies behind them.
Allied Health & Community Care
Multidisciplinary groups where rosters, referral flows, and retention carry the value.
Aged Care & Disability Services
Residential, home care, and disability providers navigating funding reform and consolidation.
Hospitals & Day Surgeries
Private facilities where property, licences, and case mix are valued separately.
Diagnostics & Imaging
Pathology and imaging groups with contract books, referrer networks, and equipment-heavy balance sheets.
Medical Devices & Technology
Device, consumable, and digital health businesses moving from clinical validation to commercial scale.
Pharmaceuticals
Drug developers and manufacturers where patent life, clinical evidence, and portfolio concentration drive value.
Biotech
Therapeutics and platform businesses where clinical milestones, intellectual property, and funding runway govern transactions.
Pharmaceutical Services
Contract research, manufacturing, and packaging businesses inside global supply chains.
Pharmacy & Distribution
Retail and wholesale assets under regulatory and margin pressure.
Healthcare Software
Practice management, clinical, and billing platforms with provider relationships embedded in the workflow.
03
03
What we are seeing
Clinician-owned groups are being approached earlier and at smaller scale. The first offer is rarely the right benchmark.
Funding reform keeps repricing entire subsectors. Buyers reward providers who can evidence compliance and outcomes, and discount those who cannot.
Health services trade on rosters, referrals, and retention. Groups that institutionalise those flows before a process begins command the premium.
Typical situations
Typical Situations
01
Several fragmented operators in one discipline that would be priced as a platform.
02
A healthcare group that has proven its model but cannot reach the scale capital wants on its own.
03
A founder-clinician at a succession point with no buyer and no structure in place.
If this is the position, it is worth a conversation.
Discuss a matter with us.
If you have a transaction, a capital requirement, a structuring question, or a matter that requires coordination across multiple jurisdictions and disciplines, we should speak.
Request an IntroductionAll enquiries are reviewed by the principal.